CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Insider Changes in Ownership
- CT ORDER Other Confidential Order
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-K Report Annual Report
Page 28 of 99 · 1,967 filings